Ignite Creation Date:
2025-12-24 @ 4:43 PM
Ignite Modification Date:
2026-02-05 @ 1:47 PM
Study NCT ID:
NCT00582166
Status:
TERMINATED
Last Update Posted:
2019-12-13
First Post:
2007-12-19
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Ibritumomab Tiuxetan (Zevalin)+ Rituximab Maintenance
Sponsor:
University of Wisconsin, Madison
Organization: